Episode Details

A bold new player is entering Connecticut’s biotech scene: CapeHaven, a venture creation firm built to turn lab discoveries into thriving startups. Backed by $2.5M and led by seasoned life sciences veterans, they’re not just funding science—they’re acting as co-founders, handling everything from legal hurdles to investor outreach. With a proven track record including the acquisition of Modifi, CapeHaven brings real-world startup grit to academic innovation. Partnering with Yale Ventures and backed by Connecticut Innovations, they’re launching lean with their first company, BrainStorm Cancer Therapeutics, already in the pipeline—and hunting for more groundbreaking ideas to scale.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/eead7b5cf5d469a4